|
|
Vaccine Detail
|
KLH and Tumor Lysate Pulsed DC Vaccine |
| Vaccine Information |
- Vaccine Name: KLH and Tumor Lysate Pulsed DC Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: whole cell cancer vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: KLH (NCT02745756)
- Immunization Route: Intradermal injection (i.d.)
- Description: Dendritic cells and neuroblastoma cells can be recognized by the immune system, and that they can be destroyed by immune cells. Dendritic cells are pulsed with KLH and tumor lysate for patients with neuroblastoma. (NCT02745756)
|
| Host Response |
|
|
| References |
NCT02745756: A Combined Cell Therapy Approach to the Treatment of Neuroblastoma [https://clinicaltrials.gov/study/NCT02745756]
|
|
